mRNA-4157,Pembrolizumab
Moderna,Merck
['moderna', 'merck']
wow! and 's phase 2b trial of personalised #mrna vaccines combined with pd-1 inhibitors was just presented at aacr. the treatment reduced the risk of recurrence or death from stage iii/iv by 44% compared to immunotherapy alone! 
A federally-funded RNA Manufacture and Research Hub located at @AIBNatUQ | Tweets about the all latest mRNA news | Retweets are not endorsements.